AVNS Q3 2017 Earnings — Avanos Medical, Inc. Revenue & Financial Results | Market Cap Arena

AVNSAvanos Medical, Inc.

$610M

Q3 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$151M-62.1% YoY

Gross Profit

$81M53.8% margin

Operating Income

-$5M-3.3% margin

Net Income

$17M11.0% margin

EPS (Diluted)

$0.35

QoQ Revenue Growth

+0.9%

Cash Flow

Operating Cash Flow

$23M

Free Cash Flow

$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$2.1B

Total Liabilities

$968M

Stockholders' Equity

$1.2B

Cash & Equivalents

$166M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$151M	$398M	-62.1%
Gross Profit	$81M	$138M	-41.3%
Operating Income	-$5M	$38M	-113.2%
Net Income	$17M	$9M	+82.4%

Revenue Segments

Surgical and Infection Prevention

$246M62%

Medical Devices

$151M38%